Medical - Pharmaceuticals
The companies in this industry manufacture and process pharmaceutical products in the treatment of health disorders and illnesses. Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
|---|---|---|---|---|---|---|
| 1 | SNPHY | SANTEN PHARMACEUTICAL CO., LTD. | 11.64 | 0.01 (0.09%) | N/A | A |
| 2 | NVS | Novartis AG ADR | 115.77 | -0.19 (-0.16%) | 244.56B | A |
| 3 | JNJ | Johnson & Johnson | 149.79 | -0.94 (-0.62%) | 360.41B | A |
| 4 | TARO | Taro Pharmaceutical Industries Ltd. | 42.97 | 0.00 (0.00%) | 1.62B | NR |
| 5 | ALPMY | Astellas Pharma Inc. ADR | 9.23 | -0.21 (-2.22%) | 16.70B | A |
| 6 | AZN | AstraZeneca PLC ADR | 69.95 | -0.81 (-1.14%) | 216.94B | A |
| 7 | DSNKY | Daiichi Sankyo Company, Limited | 22.66 | -1.08 (-4.56%) | 42.92B | A |
| 8 | CPRX | Catalyst Pharmaceuticals, Inc. | 22.48 | -0.33 (-1.45%) | 2.74B | A |
| 9 | INDV | Indivior PLC | 14.01 | 0.11 (0.79%) | 1.93B | A |
| 10 | CPIX | Cumberland Pharmaceuticals Inc. | 4.35 | -1.01 (-18.84%) | 65.08M | A |
| 11 | GSK | GSK PLC ADR | 38.07 | -0.57 (-1.48%) | 77.94B | A |
| 12 | RHHBY | Roche Holding AG ADR | 39.20 | -0.42 (-1.06%) | 250.02B | A |
| 13 | BMY | Bristol-Myers Squibb Co. | 46.86 | 0.02 (0.04%) | 95.36B | A |
| 14 | AUPH | Aurinia Pharmaceuticals Inc | 7.77 | -0.15 (-1.89%) | 1.05B | A |
| 15 | KMDA | Kamada Ltd. | 7.20 | -0.02 (-0.28%) | 414.04M | A |
| 16 | NVO | Novo Nordisk A/S ADR | 73.77 | -0.24 (-0.32%) | 331.05B | A |
| 17 | HZNP | Horizon Therapeutics PLC | 116.30 | 0.05 (0.04%) | 26.63B | NR |
| 18 | ABBV | AbbVie Inc. | 185.30 | -0.19 (-0.10%) | 327.31B | A |
| 19 | BTMD | Biote Corp. | 3.96 | -0.03 (-0.75%) | 216.65M | A |
| 20 | CALT | Calliditas Therapeutics AB ADR | 40.00 | -0.16 (-0.40%) | 1.19B | A |
| 21 | AMRX | Amneal Pharmaceuticals, Inc. | 7.82 | -0.12 (-1.51%) | 2.45B | B |
| 22 | BAYRY | Bayer AG ADR | 7.68 | -0.09 (-1.16%) | 30.18B | B |
| 23 | NBIX | Neurocrine Biosciences, Inc. | 126.55 | -0.76 (-0.60%) | 12.52B | B |
| 24 | SUPN | Supernus Pharmaceuticals, Inc. | 32.28 | -0.68 (-2.06%) | 1.81B | B |
| 25 | MRK | Merck & Co. Inc. | 79.06 | -0.23 (-0.29%) | 198.52B | B |
| 26 | TEVA | Teva Pharmaceutical Industries Ltd. ADR | 16.95 | -0.11 (-0.64%) | 19.44B | B |
| 27 | COLL | Collegium Pharmaceutical, Inc. | 29.83 | 0.23 (0.78%) | 958.50M | B |
| 28 | OPHLY | ONO PHARMACEUTICAL CO., LTD. | 3.51 | -0.05 (-1.54%) | N/A | B |
| 29 | HLUYY | H. Lundbeck A/S | 22.00 | -0.01 (-0.02%) | 21.91B | NR |
| 30 | ZTS | Zoetis Inc. | 157.17 | 2.11 (1.36%) | 69.97B | B |
| 31 | PROC | Procaps Group, S.A. | 1.01 | -0.58 (-36.51%) | 113.95M | NR |
| 32 | ESAIY | Eisai Co. Ltd. ADR | 6.67 | -0.21 (-3.05%) | N/A | B |
| 33 | CRLBF | Cresco Labs Inc. | 0.43 | -0.05 (-10.08%) | 211.92M | B |
| 34 | ACIU | AC Immune SA | 1.88 | -0.10 (-5.05%) | 188.77M | B |
| 35 | GRFS | Grifols, S.A. | 8.77 | 0.07 (0.80%) | 6.03B | B |
| 36 | IPSEY | Ipsen S.A. | 29.33 | -0.02 (-0.05%) | 9.83B | B |
| 37 | MEIP | MEI Pharma, Inc. | 2.20 | -0.05 (-2.22%) | 14.65M | NR |
| 38 | PCRX | Pacira BioSciences, Inc. | 24.23 | 0.08 (0.33%) | 1.12B | B |
| 39 | CTMX | CytomX Therapeutics, Inc. | 2.32 | 0.21 (9.95%) | 187.04M | B |
| 40 | KPRX | Kiora Pharmaceuticals Inc. | 3.20 | 0.18 (5.96%) | 9.74M | B |
| 41 | PSTX | Poseida Therapeutics Inc. | 9.50 | -0.06 (-0.63%) | 928.85M | B |
| 42 | PFE | Pfizer Inc. | 23.97 | 0.09 (0.38%) | 136.28B | B |
| 43 | RDY | Dr. Reddy's Laboratories Ltd | 15.23 | 0.04 (0.26%) | 12.71B | B |
| 44 | JUSHF | Jushi Holdings Inc. | 0.28 | -0.02 (-5.41%) | 54.27M | B |
| 45 | GDRX | GoodRx Holdings, Inc. | 4.60 | 0.12 (2.68%) | 1.64B | B |
| 46 | IRWD | Ironwood Pharmaceuticals, Inc. - | 0.70 | 0.00 (0.40%) | 113.53M | B |
| 47 | BHC | Bausch Health Companies Inc. | 6.18 | 0.00 (0.00%) | 2.29B | B |
| 48 | KNSA | Kiniksa Pharmaceuticals, Ltd. - | 28.44 | 0.51 (1.83%) | 2.08B | B |
| 49 | HLN | Haleon PLC ADR | 10.41 | -0.04 (-0.38%) | 46.83B | B |
| 50 | LLY | Eli Lilly & Co. | 762.73 | -22.30 (-2.84%) | 722.87B | B |
| 51 | AVDL | Avadel Pharmaceuticals plc each representing one Ordinary Share | 9.18 | -0.14 (-1.50%) | 888.06M | B |
| 52 | RIGL | Rigel Pharmaceuticals, Inc. | 18.93 | -0.43 (-2.22%) | 338.32M | B |
| 53 | ACAD | ACADIA Pharmaceuticals Inc. | 22.71 | -0.24 (-1.05%) | 3.80B | B |
| 54 | SNOA | Sonoma Pharmaceuticals, Inc. | 3.04 | 0.19 (6.67%) | 4.99M | B |
| 55 | PRGO | Perrigo Co. PLC | 26.50 | 0.18 (0.68%) | 3.64B | C |
| 56 | ESALY | Eisai Co. Ltd. ADR | 61.51 | -1.33 (-2.11%) | 17.64B | NR |
| 57 | SNY | Sanofi - ADR | 47.86 | 0.24 (0.50%) | 117.37B | C |
| 58 | AERI | Aerie Pharmaceuticals, Inc. | 15.25 | 0.01 (0.07%) | 753.61M | NR |
| 59 | CLLS | Cellectis S.A. | 1.47 | 0.07 (5.00%) | 81.71M | C |
| 60 | AXSM | Axsome Therapeutics, Inc. | 100.69 | -2.20 (-2.14%) | 4.96B | C |
| 61 | AMPH | Amphastar Pharmaceuticals, Inc. | 24.56 | -0.78 (-3.08%) | 1.16B | C |
| 62 | GTBIF | Green Thumb Industries Inc. | 4.92 | -0.08 (-1.60%) | 1.04B | C |
| 63 | XERS | Xeris Pharmaceuticals, Inc. | 4.51 | -0.07 (-1.53%) | 705.30M | C |
| 64 | GBIO | Generation Bio Inc. | 0.38 | 0.02 (5.56%) | 25.47M | C |
| 65 | TAK | Takeda Pharmaceutical Co. Ltd. ADR | 14.77 | -0.13 (-0.87%) | 47.00B | C |
| 66 | ELAN | Elanco Animal Health Incorporated | 13.46 | 0.13 (0.98%) | 6.68B | C |
| 67 | TCNNF | Trulieve Cannabis Corp. | 3.45 | -0.17 (-4.80%) | N/A | C |
| 68 | VRNOF | Verano Holdings Corp. | 0.48 | -0.05 (-9.43%) | 173.65M | C |
| 69 | SLGL | Sol-Gel Technologies Ltd. | 7.22 | 0.08 (1.12%) | 20.11M | NR |
| 70 | ENDP | Endo International PLC | 0.29 | -0.02 (-5.00%) | 68.80M | NR |
| 71 | ARVN | Arvinas, Inc. | 7.44 | -0.03 (-0.40%) | 543.05M | C |
| 72 | SNDL | Sundial Growers Inc. | 1.25 | -0.02 (-1.57%) | 328.47M | C |
| 73 | EGRX | Eagle Pharmaceuticals, Inc. | 2.88 | 0.53 (22.34%) | 37.34M | C |
| 74 | ASMB | Assembly Biosciences, Inc. | 17.39 | 0.25 (1.46%) | 132.82M | C |
| 75 | VTRS | Viatris Inc. | 8.87 | 0.10 (1.14%) | 10.41B | C |
| 76 | ADMS | Adamas Pharmaceuticals, Inc. | 8.22 | 0.06 (0.74%) | 376.37M | NR |
| 77 | EVTCY | Evotec SE | 22.96 | -0.01 (-0.04%) | 7.58B | NR |
| 78 | SURF | Surface Oncology, Inc. | 1.07 | -0.01 (-0.93%) | 65.08M | NR |
| 79 | ETON | Eton Pharmaceuticals, Inc. | 13.57 | -0.13 (-0.95%) | 363.92M | C |
| 80 | MGTA | Magenta Therapeutics, Inc. | 0.70 | -0.06 (-7.74%) | 42.44M | NR |
| 81 | WXXWY | WuXi Biologics (Cayman) Inc. | 6.04 | -0.15 (-2.38%) | N/A | C |
| 82 | CCHWF | Columbia Care Inc. | 0.94 | -0.20 (-17.25%) | N/A | NR |
| 83 | ARCT | Arcturus Therapeutics Holdings Inc. | 12.29 | -0.06 (-0.49%) | 333.32M | C |
| 84 | OGN | Organon & Co. | 9.75 | -0.13 (-1.32%) | 2.53B | C |
| 85 | APNHY | Aspen Pharmacare Holdings Limited | 6.66 | -0.14 (-2.03%) | 2.97B | C |
| 86 | PTPI | Petros Pharmaceuticals Inc. | 0.03 | 0.00 (4.81%) | 881.83K | C |
| 87 | CWBHF | Charlotte's Web Holdings, Inc. | 0.09 | -0.01 (-6.90%) | N/A | NR |
| 88 | ASRT | Assertio Therapeutics, Inc. | 0.63 | -0.03 (-4.54%) | 60.27M | C |
| 89 | MTEM | Molecular Templates, Inc. | 0.00 | 0.00 (0.00%) | 0.66K | NR |
| 90 | NVCR | Novocure Ltd. | 16.69 | -0.11 (-0.65%) | 1.86B | C |
| 91 | LPCN | Lipocine Inc. | 3.30 | 0.09 (2.80%) | 17.66M | C |
| 92 | OSMT | Osmotica Pharmaceuticals plc - Ordinary Shares | 1.11 | -0.02 (-1.77%) | 69.47M | NR |
| 93 | PRLD | Prelude Therapeutics Inc. | 0.86 | -0.00 (-0.07%) | 48.58M | C |
| 94 | HYPMY | Hypera S.A. | 4.86 | -0.09 (-1.82%) | 3.08B | C |
| 95 | HOOK | HOOKIPA Pharma Inc. | 1.29 | -0.02 (-1.15%) | 15.72M | C |
| 96 | CURLF | Curaleaf Holdings, Inc. | 0.80 | -0.02 (-2.91%) | 530.73M | C |
| 97 | SMTI | Sanara MedTech Inc. | 27.28 | -0.34 (-1.23%) | 242.46M | C |
| 98 | BFRA | Biofrontera AG | 2.67 | -0.28 (-9.49%) | 75.72M | NR |
| 99 | FENC | Fennec Pharmaceuticals Inc. | 7.76 | -0.10 (-1.27%) | 214.18M | C |
| 100 | ALIM | Alimera Sciences, Inc. | 5.54 | -0.01 (-0.18%) | 290.24M | C |
| 101 | OPTN | OptiNose, Inc. | 9.60 | -0.11 (-1.13%) | 97.22M | C |
| 102 | GRVI | GROVE, INC. | 4.95 | 0.35 (7.61%) | 83.26M | NR |
| 103 | CUE | Cue Biopharma, Inc. | 0.70 | 0.05 (6.90%) | 52.80M | C |
| 104 | SYBX | Synlogic, Inc. | 1.26 | 0.05 (3.79%) | 14.74M | NR |
| 105 | ELOX | Eloxx Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | 0.31K | NR |
| 106 | VRCA | Verrica Pharmaceuticals Inc. | 0.58 | 0.01 (1.04%) | 54.09M | C |
| 107 | NEOS | Neos Therapeutics, Inc. | 1.15 | -0.03 (-2.54%) | 57.22M | NR |
| 108 | ITRM | Iterum Therapeutics plc - Ordinary Share | 0.99 | -0.01 (-0.70%) | 39.60M | C |
| 109 | SPRO | Spero Therapeutics, Inc. | 3.02 | 0.08 (2.72%) | 168.85M | C |
| 110 | TXMD | TherapeuticsMD, Inc. | 1.09 | 0.01 (0.93%) | 12.62M | NR |
| 111 | RDHL | Redhill Biopharma Ltd. | 1.90 | 0.06 (3.26%) | 4.35M | C |
| 112 | BVXV | BiondVax Pharmaceuticals Ltd. | 1.36 | 0.05 (3.82%) | 2.54M | NR |
| 113 | TCDA | Tricida, Inc. | 0.11 | -0.01 (-10.00%) | 6.01M | NR |
| 114 | HAPP | HAPPINESS BIOTECH GROUP LTD | 4.50 | 0.06 (1.35%) | 31.30M | NR |
| 115 | BFRI | Biofrontera Inc. | 0.61 | -0.04 (-5.83%) | 5.78M | C |
| 116 | RMTI | Rockwell Medical, Inc. | 0.89 | -0.05 (-5.32%) | 30.42M | C |
| 117 | MTCR | Metacrine Inc. | 0.58 | -0.01 (-1.29%) | 24.75M | NR |
| 118 | MYOV | Myovant Sciences Ltd. Common Shares | 26.98 | -0.01 (-0.04%) | 2.62B | NR |
| 119 | MIRM | Mirum Pharmaceuticals, Inc. - common stock | 50.34 | -0.46 (-0.91%) | 2.49B | C |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 53.34 | -0.58 (-1.08%) | 3.31B | C |
| 121 | IVA | Inventiva S.A. ADR | 3.29 | -0.07 (-2.05%) | 314.73M | C |
| 122 | PYPD | PolyPid Ltd. | 3.28 | -0.03 (-0.91%) | 33.43M | NR |
| 123 | ZGNX | Zogenix, Inc. | 26.68 | 0.42 (1.60%) | 1.50B | NR |
| 124 | ORTX | Orchard Therapeutics plc | 16.70 | 0.05 (0.30%) | 380.11M | NR |
| 125 | YCBD | cbdMD Inc. | 0.82 | -0.02 (-2.15%) | 7.30M | C |
| 126 | ERYP | Erytech Pharma S.A. | 0.78 | 0.00 (0.00%) | 26.61M | NR |
| 127 | STRO | Sutro Biopharma, Inc. | 0.80 | 0.01 (0.89%) | 67.64M | C |
| 128 | ECOR | electroCore, Inc. | 5.13 | -0.12 (-2.29%) | 38.07M | C |
| 129 | YMAB | Y-mAbs Therapeutics, Inc. | 4.41 | -0.22 (-4.75%) | 199.70M | C |
| 130 | CLSD | Clearside Biomedical, Inc. | 0.84 | 0.05 (6.30%) | 65.26M | C |
| 131 | SBBP | Strongbridge Biopharma plc - Ordinary Shares | 2.00 | 0.03 (1.52%) | 135.66M | NR |
| 132 | VYGR | Voyager Therapeutics, Inc. | 2.97 | -0.07 (-2.30%) | 164.35M | C |
| 133 | IMAB | I-Mab ADR | 2.50 | 0.17 (7.30%) | 204.15M | C |
| 134 | LZAGY | Lonza Group AG ADR | 68.22 | 0.01 (0.01%) | 49.27B | C |
| 135 | NBRV | Nabriva Therapeutics plc - Ordinary Shares | 1.42 | 0.00 (0.00%) | 45.46M | NR |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 61.99 | 0.51 (0.83%) | 3.94B | C |
| 137 | IMCC | IM Cannabis Corp. | 2.77 | -0.19 (-6.42%) | 6.18M | C |
| 138 | SXTC | China SXT Pharmaceuticals, Inc. | 1.84 | -0.05 (-2.65%) | 29.12M | C |
| 139 | ODT | Odonate Therapeutics, Inc. | 1.12 | -0.05 (-4.27%) | 43.11M | NR |
| 140 | TKNO | Alpha Teknova, Inc. | 5.56 | 0.05 (0.91%) | 297.13M | C |
| 141 | LCI | Lannett Co Inc | 0.69 | 0.03 (3.86%) | 7.38M | NR |
| 142 | UROV | Urovant Sciences Ltd. | 16.24 | 0.01 (0.06%) | 531.75M | NR |
| 143 | AYRWF | Ayr Strategies Inc. | 0.15 | -0.09 (-36.97%) | 17.43M | C |
| 144 | EOLS | Evolus, Inc. | 9.28 | -0.02 (-0.22%) | 598.34M | C |
| 145 | FLXN | Flexion Therapeutics, Inc. | 9.12 | -0.02 (-0.22%) | 458.93M | NR |
| 146 | CRXT | Clarus Therapeutics Holdings, Inc. | 0.05 | -0.02 (-31.16%) | 2.47M | NR |
| 147 | MGTX | MeiraGTx Holdings plc - Ordinary Shares | 6.34 | -0.14 (-2.16%) | 509.51M | C |
| 148 | MOR | MorphoSys AG | 18.96 | 0.45 (2.43%) | 2.86B | C |
| 149 | RLAY | Relay Therapeutics Inc. | 3.19 | -0.17 (-5.06%) | 546.91M | C |
| 150 | CVSI | CV Sciences, Inc. | 0.03 | 0.00 (1.69%) | 5.54M | NR |
| 151 | EPIX | ESSA Pharma Inc. | 1.73 | 0.04 (2.37%) | 76.79M | C |
| 152 | CTLT | Catalent Inc. | 63.48 | 0.00 (0.00%) | 11.52B | C |
| 153 | BYSI | BeyondSpring, Inc. - Ordinary Shares | 3.17 | 0.06 (1.93%) | 127.80M | C |
| 154 | CNTA | Centessa Pharmaceuticals Limited | 12.43 | -0.25 (-1.97%) | 1.66B | C |
| 155 | MDGL | Madrigal Pharmaceuticals, Inc. | 285.73 | 3.01 (1.06%) | 6.34B | C |
| 156 | HUGE | FSD Pharma Inc. | 0.09 | -0.01 (-10.10%) | 3.61M | NR |
| 157 | LHSIF | Liberty Health Sciences Inc. | 1.14 | -0.03 (-2.17%) | 392.01M | NR |
| 158 | FIXX | Homology Medicines, Inc. | 0.93 | 0.01 (0.77%) | 54.34M | NR |
| 159 | FFNTF | 4Front Ventures Corp. | 0.00 | -0.00 (-40.00%) | N/A | NR |
| 160 | LYRA | Lyra Therapeutics Inc. | 10.45 | -0.23 (-2.15%) | 13.85M | D |
| 161 | VBLT | Vascular Biogenics Ltd. - Ordinary Shares | 0.16 | -0.02 (-8.77%) | 12.11M | NR |
| 162 | TRVI | Trevi Therapeutics, Inc. | 5.96 | -0.11 (-1.81%) | 699.07M | D |
| 163 | ALXO | ALX Oncology Holdings Inc. | 0.48 | -0.00 (-0.51%) | 25.84M | D |
| 164 | LSDI | Lucy Scientific Discovery Inc. | 0.51 | -0.16 (-23.29%) | 907.03K | NR |
| 165 | RCEL | AVITA Medical, Inc. | 5.17 | -0.08 (-1.52%) | 136.67M | D |
| 166 | NTRB | Nutriband Inc. | 7.79 | 0.00 (0.00%) | 86.89M | D |
| 167 | ETTX | Entasis Therapeutics Holdings Inc. | 2.19 | -0.01 (-0.45%) | 104.80M | NR |
| 168 | SYRS | Syros Pharmaceuticals, Inc. - common stock | 0.02 | -0.01 (-21.99%) | 590.30K | D |
| 169 | TRSSF | TerrAscend Corp. | 1.72 | 0.00 (0.00%) | 433.20M | NR |
| 170 | SCYX | SCYNEXIS, Inc. | 0.73 | -0.01 (-1.38%) | 28.65M | D |
| 171 | CHMA | Chiasma, Inc. | 3.76 | -0.24 (-6.00%) | 217.68M | NR |
| 172 | KALV | KalVista Pharmaceuticals, Inc. | 12.15 | -0.16 (-1.30%) | 604.05M | D |
| 173 | IONS | Ionis Pharmaceuticals, Inc. | 37.41 | 0.40 (1.08%) | 5.95B | D |
| 174 | APLS | Apellis Pharmaceuticals, Inc. | 17.69 | -0.07 (-0.39%) | 2.22B | D |
| 175 | ATNX | Athenex, Inc. | 0.20 | -0.06 (-23.39%) | 1.76M | NR |
| 176 | APTX | Aptinyx Inc. | 0.10 | 0.00 (3.11%) | 6.50M | NR |
| 177 | SLRX | Salarius Pharmaceuticals Inc | 1.15 | 0.07 (6.48%) | 2.45M | D |
| 178 | SMMT | Summit Therapeutics plc | 20.56 | 0.40 (1.98%) | 15.27B | D |
| 179 | NOVN | Novan, Inc. | 0.09 | -0.03 (-24.84%) | 2.64M | NR |
| 180 | GLSI | Greenwich LifeSciences Inc. | 8.90 | -0.02 (-0.22%) | 118.98M | D |
| 181 | ALLO | Allogene Therapeutics, Inc. | 1.23 | -0.06 (-4.65%) | 269.04M | D |
| 182 | CMPS | COMPASS Pathways PLC ADR | 4.63 | -0.17 (-3.54%) | 433.19M | D |
| 183 | ACRHF | Acreage Holdings, Inc. | 0.00 | -0.00 (-2.44%) | N/A | NR |
| 184 | MMNFF | MedMen Enterprises Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| 185 | OPNT | Opiant Pharmaceuticals, Inc. | 20.65 | -0.12 (-0.58%) | 106.64M | NR |
| 186 | MESO | Mesoblast Limited | 10.44 | -1.25 (-10.74%) | 1.33B | D |
| 187 | ITOS | iTeos Therapeutics Inc. | 9.96 | -0.04 (-0.40%) | 381.21M | D |
| 188 | KPTI | Karyopharm Therapeutics Inc. | 4.38 | -0.06 (-1.35%) | 37.84M | D |
| 189 | HROW | Harrow Health, Inc. | 30.66 | -0.86 (-2.73%) | 1.12B | D |
| 190 | NVCT | Nuvectis Pharma Inc. | 8.13 | 0.08 (0.99%) | 169.87M | D |
| 191 | TYME | Tyme Technologies, Inc. | 0.31 | 0.02 (8.07%) | 53.50M | NR |
| 192 | SCPH | scPharmaceuticals Inc. | 3.84 | -0.08 (-2.04%) | 202.72M | D |
| 193 | PHAS | PhaseBio Pharmaceuticals, Inc. | 0.07 | -0.02 (-26.21%) | 3.50M | NR |
| 194 | NTEC | Intec Pharma Ltd. - Ordinary Shares | 9.63 | -1.37 (-12.48%) | 8.65M | NR |
| 195 | RDUS | Radius Health, Inc. | 29.52 | -0.12 (-0.40%) | 832.52M | D |
| 196 | AGRX | Agile Therapeutics, Inc. | 1.51 | 0.00 (0.00%) | 10.35M | NR |
| 197 | HRVSF | Harvest Health & Recreation Inc. | 3.22 | 0.03 (0.94%) | N/A | NR |
| 198 | APM | Aptorum Group Limited - Class A Ordinary Shares | 0.99 | -0.05 (-4.81%) | 5.29M | D |
| 199 | MIST | Milestone Pharmaceuticals Inc. | 1.69 | -0.03 (-1.74%) | 90.35M | D |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 1.45 | 0.03 (2.11%) | 157.01M | D |
| 201 | BTAI | BioXcel Therapeutics, Inc. | 1.60 | -0.13 (-7.51%) | 9.69M | D |
| 202 | EVOK | Evoke Pharma, Inc. | 2.75 | 0.03 (0.92%) | 4.11M | NR |
| 203 | SBFM | Sunshine Biopharma Inc. | 1.44 | -0.04 (-2.37%) | 6.56M | D |
| 204 | TENX | Tenax Therapeutics, Inc. | 5.79 | 0.12 (2.12%) | 24.02M | D |
| 205 | KALA | Kala Pharmaceuticals, Inc. | 4.04 | -0.20 (-4.72%) | 26.07M | D |
| 206 | TERN | Terns Pharmaceuticals, Inc. | 3.90 | -0.10 (-2.50%) | 340.61M | D |
| 207 | DRRX | DURECT Corporation | 0.69 | 0.04 (5.38%) | 21.48M | D |
| 208 | HEXO | HEXO Corp. | 0.71 | 0.02 (2.45%) | 31.24M | NR |
| 209 | NYMX | Nymox Pharmaceutical Corporation | 0.20 | -0.05 (-19.68%) | 18.10M | NR |
| 210 | BKUH | Bakhu Holdings, Corp. | 0.02 | 0.00 (0.00%) | N/A | NR |
| 211 | VERU | Veru Inc. | 0.62 | 0.02 (3.16%) | 91.34M | D |
| 212 | CMPI | Checkmate Pharmaceuticals Inc. | 10.50 | 0.02 (0.19%) | 231.40M | NR |
| 213 | ACRX | AcelRx Pharmaceuticals, Inc. | 0.86 | 0.06 (7.50%) | 14.58M | NR |
| 214 | OGI | OrganiGram Holdings Inc. | 1.29 | -0.03 (-2.27%) | 172.78M | D |
| 215 | CLDI | Calidi Biotherapeutics Inc. | 0.28 | -0.01 (-4.92%) | 8.92M | D |
| 216 | SVRA | Savara, Inc. | 2.06 | -0.01 (-0.48%) | 356.04M | D |
| 217 | ALBO | Albireo Pharma, Inc. | 44.15 | -0.10 (-0.23%) | 913.95M | NR |
| 218 | MLYS | Mineralys Therapeutics Inc. | 13.48 | -0.25 (-1.82%) | 878.56M | D |
| 219 | FUSN | Fusion Pharmaceuticals Inc. | 21.55 | 0.03 (0.14%) | 1.83B | NR |
| 220 | BBIO | BridgeBio Pharma, Inc. | 41.73 | 1.73 (4.32%) | 7.92B | D |
| 221 | ABEO | Abeona Therapeutics Inc. | 5.89 | -0.11 (-1.83%) | 301.31M | D |
| 222 | RPTX | Repare Therapeutics Inc. | 1.41 | 0.00 (0.00%) | 60.48M | D |
| 223 | ALNA | Allena Pharmaceuticals, Inc. | 0.08 | 0.00 (3.16%) | 9.16M | NR |
| 224 | GRAY | Graybug Vision Inc | 5.50 | -0.67 (-10.80%) | 8.64M | NR |
| 225 | WVE | Wave Life Sciences Ltd. - Ordinary Shares | 6.57 | -0.33 (-4.78%) | 1.01B | D |
| 226 | ARDS | Aridis Pharmaceuticals Inc. | 0.00 | 0.00 (0.00%) | 5.33K | NR |
| 227 | ACER | Acer Therapeutics Inc. | 0.66 | -0.14 (-17.95%) | 16.15M | NR |
| 228 | RETA | Reata Pharmaceuticals, Inc. - | 172.36 | 0.04 (0.02%) | 6.58B | NR |
| 229 | APLT | Applied Therapeutics, Inc. | 0.34 | -0.01 (-2.17%) | 48.55M | D |
| 230 | DNLI | Denali Therapeutics Inc. | 13.89 | -0.20 (-1.42%) | 2.02B | D |
| 231 | IMRN | Immuron Limited | 1.84 | 0.12 (6.98%) | 10.76M | NR |
| 232 | ORGS | Orgenesis Inc. | 1.80 | 0.15 (9.09%) | 8.64M | D |
| 233 | ZYNE | Zynerba Pharmaceuticals, Inc. | 1.30 | 0.03 (2.36%) | 70.12M | NR |
| 234 | REPL | Replimune Group, Inc. | 9.27 | -0.22 (-2.32%) | 714.60M | D |
| 235 | ACB | Aurora Cannabis Inc. | 4.08 | -0.60 (-12.82%) | 229.35M | D |
| 236 | EYPT | EyePoint Pharmaceuticals, Inc. | 8.42 | -0.50 (-5.61%) | 579.39M | D |
| 237 | SNES | SenesTech, Inc. | 3.96 | -0.29 (-6.82%) | 7.16M | D |
| 238 | JUVAF | Juva Life Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| 239 | GRAL | GRAIL Inc. | 45.63 | -2.81 (-5.80%) | 1.64B | D |
| 240 | SNDX | Syndax Pharmaceuticals, Inc. | 9.48 | -0.21 (-2.17%) | 815.73M | D |
| 241 | ATXI | Avenue Therapeutics, Inc. | 0.30 | 0.04 (15.14%) | 951.08K | D |
| 242 | HOTH | Hoth Therapeutics, Inc. | 1.21 | -0.13 (-9.70%) | 15.98M | D |
| 243 | ADIL | Adial Pharmaceuticals, Inc | 0.25 | 0.01 (2.68%) | 2.56M | D |
| 244 | PCVX | Vaxcyte Inc. | 32.87 | -0.53 (-1.59%) | 4.24B | D |
| 245 | VTVT | vTv Therapeutics Inc. - | 15.55 | -0.14 (-0.92%) | 49.68M | D |
| 246 | CKPT | Checkpoint Therapeutics, Inc. | 4.26 | 0.03 (0.71%) | 370.71M | D |
| 247 | IDYA | IDEAYA Biosciences, Inc. | 21.67 | -0.19 (-0.87%) | 1.90B | D |
| 248 | SNGX | Soligenix, Inc. | 1.70 | -0.09 (-4.76%) | 5.55M | D |
| 249 | LQDA | Liquidia Technologies, Inc. | 13.17 | -0.47 (-3.45%) | 1.13B | D |
| 250 | CNSP | CNS PHARMACEUTICALS, INC. | 0.77 | -0.06 (-7.31%) | 4.21M | D |
| 251 | RGC | Regencell Bioscience Holdings Ltd. | 38.01 | -25.34 (-40.00%) | 18.80B | D |
| 252 | VREOF | Vireo Health International, Inc. | 0.39 | -0.00 (-0.76%) | 132.45M | NR |
| 253 | RFL | Rafael Holdings, Inc. Class B | 1.58 | 0.01 (0.64%) | 55.44M | NR |
| 254 | ANVS | Annovis Bio Inc. | 2.60 | -0.10 (-3.70%) | 50.66M | F |
| 255 | CNST | Constellation Pharmaceuticals, Inc. | 33.99 | 0.02 (0.06%) | 1.63B | NR |
| 256 | TLRY | Tilray Brands Inc. Cl 2 | 0.36 | -0.02 (-6.08%) | 362.34M | F |
| 257 | CRNX | Crinetics Pharmaceuticals, Inc. | 30.16 | -0.34 (-1.11%) | 2.82B | F |
| 258 | BGXX | Bright Green Corp. | 0.04 | -0.00 (-2.56%) | 7.26M | NR |
| 259 | GPCR | Structure Therapeutics Inc. ADR | 21.73 | 0.11 (0.51%) | 1.25B | F |
| 260 | ACST | Acasti Pharma, Inc. - | 3.37 | -0.03 (-0.88%) | 31.67M | NR |
| 261 | CDT | Conduit Pharmaceuticals Inc. | 2.30 | -0.07 (-2.95%) | 1.84M | F |
| 262 | ZOM | Zomedica Corp. | 0.10 | -0.00 (-0.21%) | 95.35M | NR |
| 263 | NNOX | Nano-X Imaging Ltd. | 4.99 | -0.06 (-1.19%) | 288.32M | F |
| 264 | EYEN | Eyenovia, Inc. | 4.21 | -0.62 (-12.84%) | 12.14M | F |
| 265 | CDMO | Avid Bioservices, Inc. | 12.49 | 0.01 (0.08%) | 798.90M | F |
| 266 | VKTX | Viking Therapeutics, Inc. | 26.01 | -0.27 (-1.03%) | 2.92B | F |
| 267 | CGC | Canopy Growth Corporation | 1.24 | -0.05 (-3.88%) | 227.99M | F |
| 268 | SHOT | Safety Shot Inc. | 0.31 | 0.00 (1.18%) | 23.12M | F |
| 269 | RXRX | Recursion Pharmaceuticals Inc. | 5.03 | -0.08 (-1.57%) | 2.04B | F |
| 270 | PRFX | PainReform Ltd. | 1.61 | -0.10 (-5.59%) | 3.23M | F |
| NR | CBDHF | HempFusion Wellness Inc. | 0.00 | 0.00 (900.00%) | N/A | NR |
| NR | KHRNF | Khiron Life Sciences Corp. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | ANTCF | Aion Therapeutic Inc. | 0.00 | -0.01 (-66.39%) | N/A | NR |
| NR | MJNA | Medical Marijuana Inc. | 0.00 | 0.00 (50.00%) | N/A | NR |
| NR | GDTC | CytoMed Therapeutics Ltd. | 2.28 | -0.05 (-2.15%) | 24.94M | NR |
| NR | ICNAF | Icanic Brands Company Inc. | 0.06 | 0.00 (0.00%) | N/A | NR |
| NR | SLGWF | SLANG Worldwide Inc. | 0.00 | -0.00 (-24.39%) | N/A | NR |
| NR | ACUR | Acura Pharmaceuticals | 0.00 | 0.00 (25.00%) | 166.25K | NR |
| NR | TLC | Taiwan Liposome Company, Ltd. - ADRs | 7.00 | 0.00 (0.00%) | 294.54M | NR |
| NR | ZEAL | Zealand Pharma A/S | 17.59 | 0.21 (1.21%) | 818.60M | NR |
| NR | EIDX | Eidos Therapeutics, Inc. | 122.21 | -6.23 (-4.85%) | 4.75B | NR |
All price changes on this page include dividends and splits.